Send us a text

In this podcast, PRO Section Editor, Minsun Kim, Ph.D., Professor, University of Texas Southwestern discusses Physics Patient Consults Program with Cassandra Stambaugh, Ph.D., Associate Professor, Tufts University and Ralph Ermoian, MD, Professor, University of Washington. Drs. Stambaugh and Ermoian pioneered the Physics Patient Consults Program at their institutions, bringing a wealth of experience and expertise. They will provide an overview of the program and discuss how to implement a simplified version in settings with limited resources, sharing insights into both the challenges and benefits it brings to patient care. This discussion is based on a paper in PRO titled "Feasibility and Benefits of a Simplified Physics Direct Patient Care Protocol." 

Send us a text

Editor-in-Chief Sue Yom hosts Dr. Justin Smith, a Registrar in Queensland, Australia, and Dr. Lachlan McDowell, attending radiation oncologist at Princess Alexandra Hospital in Brisbane, Australia and Section Editor for Head and Neck Cancers at the journal. They were the first and last authors of “Red Journal Reviews: Typology, Methodology, and Standards.”

Send us a text

Editor-in-Chief Sue Yom co-hosts with Dr. Claire Vanpouille-Box, Assistant Professor at Weill Cornell Medicine, Associate Editor in Biology at our journal, and expert on radiation and immunotherapy, interviewing Associate Professor Dr. Tsubasa Watanabe and Postdoctoral Scholar Dr. Genki Sato from the Institute for Integrated Radiation and Nuclear Science at Kyoto University, who were supervising and first authors on our recent new publication, “Conventional fractionated elective nodal irradiation preserves early antitumor immunity and efficacy compared to hypofractionated protocols”, joined by Dr. Jonathan Schoenfeld, Professor in the Department of Radiotherapy at Brigham and Women’s Hospital and supervising author of the accompanying editorial, “The Ongoing Challenge of Radiation-Immunotherapy Optimization: From Preclinical Insights to Clinical Practice.”

Send us a text

Editor-in-Chief Sue Yom co-hosts with Dr. Sarah Milgrom, Associate Professor in the Department of Radiation Oncology at the University of Colorado and Section Editor for Lymphoma, interviewing Dr. Brad Hoppe, Professor in the Department of Radiation Oncology and Medical Director of Particle Therapy from Mayo Clinic Jacksonville, who was last author on “The Role of Radiation Therapy in the Management of Grey Zone Lymphoma,” first author on “Comparison of Contemporary Radiotherapy Approaches in Combined Modality Treatment on Pediatric High-Risk Classic Hodgkin Lymphoma Study: AHOD 1331,” and submitting author of a striking art cover called “Set in Bloom” created by his young adult patient Katherine Beatty, a survivor of Gray Zone lymphoma, as well as Dr. Belinda Campbell, Associate Professor and Deputy Director of Radiation Oncology at Peter MacCallum Cancer Centre and first author of “Radiation therapy utilization for primary cutaneous T-cell lymphoma is lowest amongst patients living in the most geographically accessible areas; an Australian study.”

Send us a text

For ASTRO 2025, our Editor-in-Chief Dr. Sue Yom hosts Dr. Minesh Mehta, Chief, Deputy Director and John and Mary Lou Dasburg Endowed Chair in Radiation Oncology at Baptist Health Miami Cancer Institute and first author of the article “Tumor Treating Fields (TTFields) therapy after stereotactic radiosurgery for brain metastases from non-small cell lung cancer: final results of the phase 3 METIS study”; Dr. Cliff Robinson, Professor and Chief of SBRT at Washington University in St. Louis, Thoracic Section Editor, and supervising author of Stereotactic Arrhythmia Radiotherapy (STAR) vs Repeat Catheter Ablation for High-Risk Refractory Ventricular Tachycardia: 3-Year Safety and Efficacy Outcomes; and Dr. Alexa Dang, Clinical Instructor in Radiation Oncology at BC Cancer in Vancouver and first author of Dosimetric Outcomes for Stereotactic Radiotherapy in Early-Stage Non-Small Cell Lung Cancer and Interstitial Lung Disease: A Secondary Analysis of the ASPIRE-ILD Trial. 

Send us a text

Editor-in-Chief Dr. Sue Yom hosts Dr. Ben Corn, Professor of Oncology and Director of the Institute for the Study of Hope, Dignity & Wellbeing at Hebrew University School of Medicine in Jerusalem, and first author of our article published this month, ““Hope” Drives Quality of Life in Patients With Brain Metastases, But, the “Hope Center” Remains Elusive: An Analysis of NRG-CC003”; Dr. Vinai Gondi, Clinical Associate Professor and Service Line Director of Radiation Oncology in the Northwestern Medicine West Region, co-author on this paper and Principal Investigator of the parent clinical trial that enabled this study, NRG-CC003; and Dr. Tracy Balboni, Professor and Program Director of the Harvard Radiation Oncology Program, Director of Skeletal Radiation Oncology at Dana-Farber Cancer Center, Co-Director of the Initiative on Health, Spirituality, and Religion at Harvard, and the author of an accompanying editorial to this article, “Hope in Wisdom Past and for Future Clinical Trials.”

Send us a text

ASTRO has recently updated guidelines for post mastectomy radiotherapy (PMRT) to align practice with outcomes from multiple newly published studies for locally advanced breast cancer published over the past decade. This podcast, led by Melissa Pulfer Mitchell, MD, features lead authors of the new ASTRO PMRT guidelines Kathleen C. Horst, MD, and Rachel B. Jimenez, MD, and highlights the main questions answered by the new guidelines, as well as limitations of this expert consensus and lingering questions to be addressed. 

Send us a text

Dr. Sue Yom, Editor in Chief, co-hosts with Deputy Editor Dr. Alison Tree, in discussion/debate with Dr. John Floberg, Associate Professor and Director of Theranostics in the Department of Human Oncology at the University of Wisconsin and last author of “Severe Late Toxicities (Grade 3-5) with 13 Years of Follow-up after Hypofractionated Postprostatectomy Radiotherapy”; Dr. Paul Sargos, Head of the Department of Radiotherapy at the Institut Bergonié in Bordeaux, France and last author of an accompanying editorial, ”Hypofractionated radiotherapy for prostate cancer in the postoperative setting: is it capable of going the distance?”; and Dr. Ron Chen, Professor and Chair of Radiation Oncology at the University of Kansas, an Associate Editor at the journal, and a co-chair of NRG-GU003, who was corresponding author on a counterpoint editorial, “Long Term Outcomes in Hypofractionated Post-Prostatectomy Radiation: Cautionary Tale or Expected Findings?”

Send us a text

Editor-in-Chief Sue Yom hosts a discussion of lung cancer reirradiation with Dr. Charles Simone, Chief Medical Officer of the New York Proton Center and Full Member at Memorial Sloan Kettering and Dr. Kristen Higgins, Chief Clinical Officer for City of Hope Cancer Center Atlanta, first and co authors on a paper entitled “American Radium Society Appropriate Use Criteria Systematic Review and Guidelines on Reirradiation for Non-Small Cell Lung Cancer Executive Summary.”

Send us a text

Editor in Chief Dr. Sue Yom hosts a discussion of reirradiation planning based on the Michigan model of the special medical physics consultation, as explained by guests Dr. Kelly Paradis, Associate Professor of Medical Physics in the Department of Radiation Oncology at the University of Michigan, and Dr. Martha Matuszak, the Laurie Snow Professor of Radiation Oncology and Associate Chair for Physics in the same group, who were first and co-last author on the article, “Reirradiation Special Medical Physics Consultations: Lessons Learned From Nearly 3000 Courses of Treatment.”​